Sectors
Security, Analytics, Financial, SaaS
Headquarters
261 Madison Ave, New York, New York, 10016, United States
CEO
Gadi Mazor
BioCatch shares, as of April 21, 2025, are valued at a price per share implying an approximate +4.23% relative to the most recent significant secondary market activity in April 2025, according to PM Insights' market data. PM Insights uses a market-driven derived price methodology to determine BioCatch's valuation when recent secondary market transactions are limited or unavailable, as is currently the case for BioCatch.
Register today to view the full report, with more in-depth details and analytics
Latest funding round
XXXXX
XX-XX-XXXX
AV Implied Valuation
XXXXX
XX-XX-XXXX
Change since Last Round
XXXXX
XX-XX-XXXX
Secondary Activity
XXXXX
Business Partnerships
Targeted Impact
Who Will Benefit?
What Comes Next?
No items found.
.png)
BioCatch generated $21.7M in revenue as of 2024, according to PM Insights' market research.
BioCatch shares, as of April 21, 2025, are valued at a price per share implying an approximate +4.23% relative to the most recent significant secondary market activity in April 2025, according to PM Insights' market data. PM Insights uses a market-driven derived price methodology to determine BioCatch's valuation when recent secondary market transactions are limited or unavailable, as is currently the case for BioCatch.
No items found.
No items found.
Ready to see it in action?
Schedule a demo with one of our experts
